BAKER COREY 4
4 · Vita Coco Company, Inc. · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
Vita Coco (COCO) CFO Corey Baker Sells 2,000 Shares
What Happened Corey Baker, Chief Financial Officer of Vita Coco Company, sold 2,000 shares of common stock on March 19, 2026, at $55.45 per share for total proceeds of $110,900. The transaction is reported as a sale (S) and was effected pursuant to a Rule 10b5-1 trading plan, indicating the trades were pre-planned rather than ad hoc.
Key Details
- Transaction date and price: 2026-03-19 — 2,000 shares at $55.45 each (total $110,900).
- Transaction type: Sale (open market/private sale) under a Rule 10b5-1 plan (Footnote F1).
- Filing date: Form 4 filed 2026-03-23 reporting the 3/19/2026 trade — this filing date is within the typical two business‑day Form 4 window and appears timely.
- Shares owned after transaction: Not disclosed in the information provided in this summary.
- Additional footnotes: The filing includes multiple footnotes (F2–F5) describing outstanding stock option grants with staggered vesting schedules (vesting beginning March 2024 and through 2027); these relate to option holdings rather than the reported sale.
Context Sales under a 10b5-1 plan are generally pre-established trading arrangements and are often considered routine liquidity events rather than signals of new insider sentiment. For retail investors, purchases are typically more informative than routine plan-driven sales; this entry documents a planned disposition of shares by the CFO.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-19$55.45/sh−2,000$110,900→ 25,951 total
- 9,205
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $16.91Exp: 2033-03-10→ Common Stock (9,205 underlying) - 13,481
Non-Qualified Stock Option (Right to Buy)
[F3]Exercise: $24.35Exp: 2033-05-10→ Common Stock (13,481 underlying) - 8,746
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying) - 11,547
Non-Qualified Stock Option (Right to Buy)
[F3]Exercise: $27.59Exp: 2033-08-07→ Common Stock (11,547 underlying) - 13,218
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
Footnotes (5)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The stock option vests in four equal annual installments beginning on March 10, 2024.
- [F3]The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
- [F4]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F5]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.